352 related articles for article (PubMed ID: 25935274)
41. Long Non-coding RNA-mRNA Correlation Analysis Reveals the Potential Role of HOTAIR in Pathogenesis of Sporadic Thoracic Aortic Aneurysm.
Guo X; Chang Q; Pei H; Sun X; Qian X; Tian C; Lin H
Eur J Vasc Endovasc Surg; 2017 Sep; 54(3):303-314. PubMed ID: 28757056
[TBL] [Abstract][Full Text] [Related]
42. Vascular restenosis in coronary artery bypass grafting might be associated with VEGF-C/VEGFR-3 signaling pathway.
Podemska-Jedrzejczak Z; Malinska A; Sujka-Kordowska P; Nowicki M; Puslecki M; Jemielity M; Perek B
Heart Vessels; 2018 Sep; 33(9):1106-1120. PubMed ID: 29557990
[TBL] [Abstract][Full Text] [Related]
43. C-reactive protein and vein graft disease: evidence for a direct effect on smooth muscle cell phenotype via modulation of PDGF receptor-beta.
Ho KJ; Owens CD; Longo T; Sui XX; Ifantides C; Conte MS
Am J Physiol Heart Circ Physiol; 2008 Sep; 295(3):H1132-H1140. PubMed ID: 18621860
[TBL] [Abstract][Full Text] [Related]
44. Different vascular smooth muscle cell apoptosis in the human internal mammary artery and the saphenous vein. Implications for bypass graft disease.
Frischknecht K; Greutert H; Weisshaupt C; Kaspar M; Yang Z; Luscher TF; Carrel TP; Tanner FC
J Vasc Res; 2006; 43(4):338-46. PubMed ID: 16733369
[TBL] [Abstract][Full Text] [Related]
45. Reduction of intimal hyperplasia and enhanced reactivity of experimental vein bypass grafts with verapamil treatment.
el-Sanadiki MN; Cross KS; Murray JJ; Schuman RW; Mikat E; McCann RL; Hagen PO
Ann Surg; 1990 Jul; 212(1):87-96. PubMed ID: 2363608
[TBL] [Abstract][Full Text] [Related]
46. Clinical factors that influence the cellular responses of saphenous veins used for arterial bypass.
Sobel M; Kikuchi S; Chen L; Tang GL; Wight TN; Kenagy RD
J Vasc Surg; 2018 Dec; 68(6S):165S-176S.e6. PubMed ID: 29914830
[TBL] [Abstract][Full Text] [Related]
47. In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1.ATF), a cell-surface directed matrix metalloproteinase inhibitor.
Eefting D; de Vries MR; Grimbergen JM; Karper JC; van Bockel JH; Quax PH
J Vasc Surg; 2010 Feb; 51(2):429-37. PubMed ID: 20036101
[TBL] [Abstract][Full Text] [Related]
48. Suprabasin enhances the invasion, migration, and angiogenic ability of oral squamous cell carcinoma cells under hypoxic conditions.
Houri A; Mukudai Y; Abe Y; Watanabe M; Nara M; Miyamoto S; Kurihara M; Shimane T; Shirota T
Oncol Rep; 2023 May; 49(5):. PubMed ID: 36896786
[TBL] [Abstract][Full Text] [Related]
49. A selective cyclic integrin antagonist blocks the integrin receptors alphavbeta3 and alphavbeta5 and inhibits retinal pigment epithelium cell attachment, migration and invasion.
Hoffmann S; He S; Jin M; Ehren M; Wiedemann P; Ryan SJ; Hinton DR
BMC Ophthalmol; 2005 Jun; 5():16. PubMed ID: 15987521
[TBL] [Abstract][Full Text] [Related]
50. Inhibition effect of tacrolimus and platelet-derived growth factor-BB on restenosis after vascular intimal injury.
Ma X; Jiang C; Li Y; Feng L; Liu J; Wang J
Biomed Pharmacother; 2017 Sep; 93():180-189. PubMed ID: 28633129
[TBL] [Abstract][Full Text] [Related]
51. Scavenger receptor class A, member 5 is associated with thyroid cancer cell lines progression via epithelial-mesenchymal transition.
Zheng C; Xia EJ; Quan RD; Bhandari A; Wang OC; Hao RT
Cell Biochem Funct; 2020 Mar; 38(2):158-166. PubMed ID: 31989658
[TBL] [Abstract][Full Text] [Related]
52. Adenoviral activin A expression prevents vein graft intimal hyperplasia in a rat model.
Kloppenburg GT; Grauls GE; Bruggeman CA; Stassen FR
Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):31-4. PubMed ID: 18854336
[TBL] [Abstract][Full Text] [Related]
53. Identification of
Wang F; Cao X; Yin L; Wang Q; He Z
DNA Cell Biol; 2020 Oct; 39(10):1813-1824. PubMed ID: 32816580
[TBL] [Abstract][Full Text] [Related]
54. Prevention of Venous Neointimal Hyperplasia by a Multitarget Receptor Tyrosine Kinase Inhibitor.
Kwon SH; Li L; He Y; Tey CS; Li H; Zhuplatov I; Kim SJ; Terry CM; Blumenthal DK; Shiu YT; Cheung AK
J Vasc Res; 2015; 52(4):244-256. PubMed ID: 26788996
[TBL] [Abstract][Full Text] [Related]
55. Functional properties of hyalocytes under PDGF-rich conditions.
Noda Y; Hata Y; Hisatomi T; Nakamura Y; Hirayama K; Miura M; Nakao S; Fujisawa K; Sakamoto T; Ishibashi T
Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2107-14. PubMed ID: 15223783
[TBL] [Abstract][Full Text] [Related]
56. Effect of microRNA-145 to prevent vein graft disease in rabbits by regulation of smooth muscle cell phenotype.
Ohnaka M; Marui A; Yamahara K; Minakata K; Yamazaki K; Kumagai M; Masumoto H; Tanaka S; Ikeda T; Sakata R
J Thorac Cardiovasc Surg; 2014 Aug; 148(2):676-82.e2. PubMed ID: 24507892
[TBL] [Abstract][Full Text] [Related]
57. MicroRNA-365 promotes the contractile phenotype of venous smooth muscle cells and inhibits neointimal formation in rat vein grafts.
Cao BJ; Zhu L; Wang XW; Zou RJ; Lu ZQ
IUBMB Life; 2019 Jul; 71(7):908-916. PubMed ID: 30746857
[TBL] [Abstract][Full Text] [Related]
58. Molecular engineering of vein bypass grafts.
Conte MS
J Vasc Surg; 2007 Jun; 45 Suppl A():A74-81. PubMed ID: 17544027
[TBL] [Abstract][Full Text] [Related]
59. Antisense to transforming growth factor-beta1 messenger RNA reduces vein graft intimal hyperplasia and monocyte chemotactic protein 1.
Wolff RA; Ryomoto M; Stark VE; Malinowski R; Tomas JJ; Stinauer MA; Hullett DA; Hoch JR
J Vasc Surg; 2005 Mar; 41(3):498-508. PubMed ID: 15838486
[TBL] [Abstract][Full Text] [Related]
60. Gene transfer of redox factor-1 inhibits neointimal formation: involvement of platelet-derived growth factor-beta receptor signaling via the inhibition of the reactive oxygen species-mediated Syk pathway.
Lee HM; Jeon BH; Won KJ; Lee CK; Park TK; Choi WS; Bae YM; Kim HS; Lee SK; Park SH; Irani K; Kim B
Circ Res; 2009 Jan; 104(2):219-27, 5p following 227. PubMed ID: 19038866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
